Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2

Clinical trial NCT05069649 · COMPLETED

Trial details

NCT number: NCT05069649
Sponsor: Materia Medica Holding
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immunization Against COVID-19

Start date: 2021-10-06
Primary completion: 2022-04-14
Enrollment: 1057

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.